Clinical trial Recruiting at 3 sites Observational Ages 18 to 70

Evaluating the progression of pancreatitis from acute to chronic stages

Official title: Characterization of Fibro-inflammation During Progression From Acute to Chronic Pancreatitis

Run by Copenhagen University Hospital, Hvidovre · NCT03853447 · Data updated 2026-11-12

This study is trying to see how acute pancreatitis can turn into chronic pancreatitis over time by following patients with different stages of the condition and using advanced imaging and tests.

More Fibrosis trials

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment150 (estimated)
SponsorCopenhagen University Hospital, Hvidovre
Academic / other
Locations3 sites (Hvidovre, Capital Region Denmark and 2 other locations)
StatusRecruiting
StartedFebruary 14, 2019
Main results expectedJanuary 1, 2040
Study endsJanuary 1, 2041
Registry record updatedApril 8, 2020
Trial IDNCT03853447 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with their first episode of acute pancreatitis, recurrent acute pancreatitis, early chronic pancreatitis, or end-stage chronic pancreatitis.

Probably not a fit

Patients with gallstone-induced pancreatitis will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the development of chronic pancreatitis by utilizing advanced imaging techniques and biochemical markers to monitor inflammation, fibrosis, and oxidative stress. Participants include individuals experiencing their first episode of acute pancreatitis, recurrent acute pancreatitis, or early chronic pancreatitis, as well as those with end-stage chronic pancreatitis. The study will follow these patients for 15 years, employing methods such as MRI, contrast-enhanced endoscopic ultrasound, and various assessments of pancreatic function and pain processing. Additionally, a biobank will be established to analyze potential biomarkers related to disease progression.

Why it matters

Potential benefit: If successful, this study could lead to earlier detection and prevention strategies for chronic pancreatitis, improving patient outcomes.

How similar studies have gone: While there have been studies on pancreatitis, this specific approach focusing on the transition from acute to chronic pancreatitis using advanced imaging and biomarkers is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with CP (N=50) of any aetiology except gallstone induced CP: CP will be diagnosed based on MANNHEIM criteria .
* Cohort 2: Patients with their first attack of AP of any aetiology except gallstone induced AP (N=50). The revised Atlanta criteria for acute pancreatitis will be used as diagnostic criteria.
* Cohort 3: Patients with RAP (N=50) except gallstone induced RAP. RAP is defined as two or more cases of AP as diagnosed by the revised Atlanta Criteria.

Exclusion Criteria:

Where it's running

  • Gastrounit, Copenhagen University Hospital Hvidovre
    Hvidovre, Capital Region Denmark, Denmark
    Recruiting
  • Department of Gastroenterology & Hepatology, Aalborg University Hospital
    Aalborg, Denmark
    Recruiting
  • Abdominal Centre, Bispebjerg University Hospital
    Copenhagen, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.